Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species

BMC Genomics

Volumn 17, Issue 1, 2016, Pages

  Mosquera Rendón, Jeanneth ^a,b   Rada Bravo, Ana M ^b,c   Cárdenas Brito, Sonia ^a   Corredor, Mauricio ^b   Restrepo Pineda, Eliana ^b   Benítez Páez, Alfonso ^a,d  

^a Bioinformatic Analysis Group GABi   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c Epidemiology Section   (Colombia)

^d INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Genetic variation; Molecular evolution; Non synonymous substitutions; Pangenome; Pathogenicity; Pseudomonas aeruginosa; Synonymous substitutions

Indexed keywords

OUTER MEMBRANE PROTEIN; PSEUDOMONAS VACCINE;

ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM PILUS; CONTROLLED STUDY; DRUG DESIGN; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; MOLECULAR EVOLUTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PSEUDOMONAS AERUGINOSA; BIOFILM; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY; PSEUDOMONAS INFECTION;

BIOFILMS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; GENOTYPE; HUMANS; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84953889319     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-016-2364-4     Document Type: Article

References (55)

1. Lavoie EG, Wangdi T, Kazmierczak BI. Innate immune responses to Pseudomonas aeruginosa infection. Microbes Infect. 2011;13(14-15):1133-45.
2. Hauser AR, Jain M, Bar-Meir M, McColley SA. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev. 2011;24(1):29-70.
3. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog. 2009;5(3), e1000354.
4. Alhede M, Bjarnsholt T, Givskov M, Alhede M. Pseudomonas aeruginosa biofilms: mechanisms of immune evasion. Adv Appl Microbiol. 2014;86:1-40.
5. Doring G, Meisner C, Stern M. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2007;104(26):11020-5.
6. Lang AB, Rudeberg A, Schoni MH, Que JU, Furer E, Schaad UB. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr Infect Dis J. 2004;23(6):504-10.
7. Horn MP, Zuercher AW, Imboden MA, Rudolf MP, Lazar H, Wu H, et al. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Antimicrob Agents Chemother. 2010;54(6):2338-44.
8. Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection. Infect Immun. 2011;79(3):1289-99.
9. Campodonico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun. 2011;79(8):3455-64.
10. Lynch SV, Flanagan JL, Sawa T, Fang A, Baek MS, Rubio-Mills A, et al. Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV-implications for anti-PcrV immunotherapy. Microb Pathog. 2010;48(6):197-204.
11. Doring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 2008;26(8):1011-24.
12. Montor WR, Huang J, Hu Y, Hainsworth E, Lynch S, Kronish JW, et al. Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays. Infect Immun. 2009;77(11):4877-86.
13. Wattam AR, Abraham D, Dalay O, Disz TL, Driscoll T, Gabbard JL, et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res. 2014;42(Database issue):D581-91.
14. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A. 2005;102(39):13950-5.
15. Tettelin H, Riley D, Cattuto C, Medini D. Comparative genomics: the bacterial pan-genome. Curr Opin Microbiol. 2008;11(5):472-7.
16. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, et al. Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 2011;39(Database issue):D596-600.
17. Lapierre P, Gogarten JP. Estimating the size of the bacterial pan-genome. Trends Genet. 2009;25(3):107-10.
18. Hilker R, Munder A, Klockgether J, Losada PM, Chouvarine P, Cramer N, et al. Interclonal gradient of virulence in the Pseudomonas aeruginosa pangenome from disease and environment. Environ Microbiol. 2015;17(1):29-46.
19. Valot B, Guyeux C, Rolland JY, Mazouzi K, Bertrand X, Hocquet D. What it takes to be a Pseudomonas aeruginosa? The core genome of the opportunistic pathogen updated. PLoS One. 2015;10(5), e0126468.
20. Ozer EA, Allen JP, Hauser AR. Characterization of the core and accessory genomes of Pseudomonas aeruginosa using bioinformatic tools Spine and AGEnt. BMC Genomics. 2014;15:737.
21. Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, Gajer P, et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol. 2008;190(20):6881-93.
22. Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 2007;35(Web Server issue):W182-5.
23. Backert S, Fronzes R, Waksman G. VirB2 and VirB5 proteins: specialized adhesins in bacterial type-IV secretion systems? Trends Microbiol. 2008;16(9):409-13.
24. Hraiech S, Bregeon F, Rolain JM. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status. Drug Des Devel Ther. 2015;9:3653-63.
25. Ulland TK, Buchan BW, Ketterer MR, Fernandes-Alnemri T, Meyerholz DK, Apicella MA, et al. Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J Immunol. 2010;185(5):2670-4.
26. Wong HC, Liu SH, Chen MY. Virulence and stress susceptibility of clinical and environmental strains of Vibrio vulnificus isolated from samples from Taiwan and the United States. J Food Prot. 2005;68(12):2533-40.
27. Mosquera-Rendon J, Cardenas-Brito S, Pineda JD, Corredor M, Benitez-Paez A. Evolutionary and sequence-based relationships in bacterial AdoMet-dependent non-coding RNA methyltransferases. BMC Res Notes. 2014;7:440.
28. Benitez-Paez A, Villarroya M, Armengod ME. The Escherichia coli RlmN methyltransferase is a dual-specificity enzyme that modifies both rRNA and tRNA and controls translational accuracy. RNA. 2012;18(10):1783-95.
29. Benitez-Paez A, Villarroya M, Armengod ME. Regulation of expression and catalytic activity of Escherichia coli RsmG methyltransferase. RNA. 2012;18(4):795-806.
30. Kimura S, Suzuki T. Fine-tuning of the ribosomal decoding center by conserved methyl-modifications in the Escherichia coli 16S rRNA. Nucleic Acids Res. 2010;38(4):1341-52.
31. Kyuma T, Kimura S, Hanada Y, Suzuki T, Sekimizu K, Kaito C. Ribosomal RNA methyltransferases contribute to Staphylococcus aureus virulence. FEBS J. 2015;282(13):2570-84.
32. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, et al. Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2007;104(19):8101-6.
33. Miyoshi-Akiyama T, Kuwahara T, Tada T, Kitao T, Kirikae T. Complete genome sequence of highly multidrug-resistant Pseudomonas aeruginosa NCGM2.S1, a representative strain of a cluster endemic to Japan. J Bacteriol. 2011;193(24):7010.
34. Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun. 2000;68(7):3998-4004.
35. Malathi J, Murugan N, Umashankar V, Bagyalakshmi R, Madhavan HN. Draft genome sequence of multidrug-resistant Pseudomonas aeruginosa Strain VRFPA02, isolated from a septicemic patient in India. Genome Announc. 2013;1(4):e00425-13.
36. Yang Z. Among-site rate variation and its impact on phylogenetic analyses. Trends Ecol Evol. 1996;11(9):367-72.
37. Maatallah M, Bakhrouf A, Habeeb MA, Turlej-Rogacka A, Iversen A, Pourcel C, et al. Four genotyping schemes for phylogenetic analysis of Pseudomonas aeruginosa: comparison of their congruence with multi-locus sequence typing. PLoS One. 2013;8(12), e82069.
38. Syrmis MW, Kidd TJ, Moser RJ, Ramsay KA, Gibson KM, Anuj S, et al. A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infect Dis. 2014;14:307.
39. D'Auria G, Jimenez-Hernandez N, Peris-Bondia F, Moya A, Latorre A. Legionella pneumophila pangenome reveals strain-specific virulence factors. BMC Genomics. 2010;11:181.
40. Kittichotirat W, Bumgarner RE, Asikainen S, Chen C. Identification of the pangenome and its components in 14 distinct Aggregatibacter actinomycetemcomitans strains by comparative genomic analysis. PLoS One. 2011;6(7), e22420.
41. Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tummler B. Pseudomonas aeruginosa Genomic Structure and Diversity. Front Microbiol. 2011;2:150.
42. Spangenberg C, Heuer T, Burger C, Tummler B. Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett. 1996;396(2-3):213-7.
43. Winstanley C, Coulson MA, Wepner B, Morgan JA, Hart CA. Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa. Microbiology. 1996;142(Pt 8):2145-51.
44. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403-10.
45. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389-402.
46. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004;5:113.
47. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32(5):1792-7.
48. Korber B. HIV signature and sequence variation analysis. In: Rodrigo A, Learn G, editors. Computational analysis of HIV molecular sequences. Dordrecht, Netherlands: Kluwer Academic Publishers; 2000. p. 55-72.
49. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986;3(5):418-26.
50. Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol Biol. 2007;396:71-91.
51. Letunic I, Doerks T, Bork P. SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res. 2012;40(Database issue):D302-5.
52. Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, et al. Pfam: the protein families database. Nucleic Acids Res. 2014;42(Database issue):D222-30.
53. Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014;15:293.
54. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012;9(8):772.
55. Letunic I, Bork P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res. 2011;39(Web Server issue):W475-8.